PG
Priya Girish Hingorani
About Priya Girish Hingorani
Data last updated:
Priya Girish Hingorani is a Managing Director at Miltenyi Biotec India Private Limited (since 2024). The company operates in Biotechnology. Miltenyi Biotec India Private Limited reported revenue of ₹19.10 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Miltenyi Biotec India Private Limited U32509TS2023PTC179183 | Managing Director | 22 Nov 2024 | 2023 | ₹19.10 Cr (FY 2025) | Active |
Board colleagues of Priya Girish Hingorani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Antoon Magdalena M Overstijns | 10537405 | Miltenyi Biotec India Private Limited | Director |
| Boris Wilhelm Dr Stoffel | 10537408 | Miltenyi Biotec India Private Limited | Director |
| Norbert Wolfram Hentschel | 10537406 | Miltenyi Biotec India Private Limited | Director |
| Stefan Gyoergy Otto Miltenyi | 10537407 | Miltenyi Biotec India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Priya Girish Hingorani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priya Girish Hingorani
Priya Girish Hingorani currently holds 1 directorship: Miltenyi Biotec India Private Limited (Managing Director, since 22 Nov 2024, revenue ₹19.10 Cr (FY 2025)).
Priya Girish Hingorani was first appointed on 22 Nov 2024 as Managing Director at Miltenyi Biotec India Private Limited.
The current boards of Priya Girish Hingorani's companies include Antoon Magdalena M Overstijns (Miltenyi Biotec India Private Limited), Boris Wilhelm Dr Stoffel (Miltenyi Biotec India Private Limited), Norbert Wolfram Hentschel (Miltenyi Biotec India Private Limited), Stefan Gyoergy Otto Miltenyi (Miltenyi Biotec India Private Limited).